Demo

AI OCT for Wet AMD

Book free trial to see how AI can detect Wet AMD and 70+ other pathologies/biomarkers

Book Intro

Altris AI is an FDA-cleared OCT scan analysis platform that detects the earliest Wet AMD hallmarks, such as fluids, drusen, outer retinal tubulations, and others. It provides:

Biomarker and pathology segmentation, color-coding, and quantifying, including changes associated with early or subtle Wet AMD.

Specialized drusen and fluids calculations.

Progression analysis: monitoring the treatment results with AI for Wet AMD over time objectively.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA- cleared (510k).

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024
Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024
Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023
/

Make informed decisions based on objective insights.
Use AI OCT for nAMD detection, monitoring and treatment.

 

Altris AI offers standardized and reproducible examination with accurate volumetric and area measurements down to micrometers.

Add examinations from different visits
Identify Wet AMD biomarkers with color-coding
Explore Wet AMD biomarkers in terms of area and volume
Track how Wet AMD biomarkers transform over time

How Altris AI works?

And what's the value of using AI for Neovascular AMD

  • img
  • img
  • img
  • img
  • img
  • img
  • img
  • img

Altris AI is a web platform created by retina experts for all eye care specialists and clinicians.

We’ve collected millions of OCT scans, and our team graphically labeled thousands of them to create the Altris AI system that can:

Detect over 70 pathologies and biomarkers, including early Wet AMD indicators.
Measure and track pathological changes across multiple examinations.

 

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

 

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

 

OCT reports

We create comprehensible OCT reports for patients and doctors

For clinical research

What you get with Altris AI:

Contact us:

  • Accelerate ophthalmic drug trial
  • Detect over 70 retinal pathologies and biomarkers with unparalleled precision
  • Analyze biomarkers on OCT scans before and after the treatment quantitatively
  • Track the progression of biomarkers to assess drug efficiency
  • Enroll the right patients based on fast biomarker detection
  • Reduce costs associated with manual scan review with automated analysis

For eye care

What you get with Altris AI:

Contact us:

  • 14 Days of Free Trial to see the value
  • Support during the whole trial period
  • Early glaucoma assessment module access
  • CE-certified, GDPR, HIPAA compliant, FDA clearance
  • Integration support with any EHR, EMR system.
  • Cloud data storage/on premises possible
  • Access to the whole functional during trial